Plant microbiomes are not only diverse, but also appear to host a vast pool of secondary
metabolites holding great promise for bioactive natural products and drug discovery. Yet …

New ecosystems are being actively mined for new bioactive compounds. Because of the
large amount of unexplored biodiversity, bacteria from marine environments are especially …

Background: Multi-drug resistant pathogens pose significant challenges towards the
effective resolution of bacterial infections. A promising alternative strategy is phage therapy …

The overuse and misuse of antibiotics has led to a global crisis in which most bacterial
pathogens have evolved resistance to the available drugs used for treatments. As a result …

Bacterial pathogens are evolving resistance to all available antibiotics and are a leading
cause of death worldwide. Thus, the discovery of new antibiotics that inhibit multi-drug …

Pharmaceutical companies have slowed the discovery and development of antibiotics due
to low-profit margins. Therefore, antibiotic discovery is at an all-time low, and pathogens …

Multidrug resistant (MDR) bacterial infections cause an estimated 700,000 deaths per year
worldwide. By the year 2050, it is predicted that MDR infections will account for 10 million …

Multidrug resistant (MDR) pathogens are predicted to cause more than ten million annual
deaths worldwide by 2050, making bacterial infections the leading cause of death. Although …

The CDC predicts that 10 million deaths will occur worldwide by 2050 due to multi-drug
resistant (MDR) bacterial infections. As microbial resistance increases, the number of new …

El antagonismo bacteriano es una fuente importante de productos naturales de relevancia
biotecnológica. Las moléculas caracterizadas involucradas en este fenómeno son …